Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs

Overview of attention for article published in Heart Failure Reviews, November 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#8 of 757)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 14 news outlets
policy: 1 policy source

twitter: 1 X user
patent: 3 patents

Citations

dimensions_citation: 188 Dimensions

Readers on

mendeley: 213 Mendeley

Summary News Policy documents X Patents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Tafamidis for treating transthyretin amyloidosis with cardiomyopathy : Appraisal consultation committee papers

Cited by National Institute for Health and Care Excellence on 27 May 2020

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.